Name

Tomita Pharmaceutical

Legal name

富田薬品株式会社

Website

https://tomita-pharma.co.jp

Company type

Private

Founded year

1948

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Wholesale Distribution

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Veterinary Pharmaceutical Wholesalers & Distributors (HLAMAIAA)

Keywords

• Pharmaceutical wholesale
• Medical device distribution
• Veterinary pharmaceuticals
• Pharmaceutical logistics
• Healthcare distribution

Headquarters

HQ city

Kumamoto

HQ country

Japan

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Infrastructure, Technology or R&D

Revenue model

1. Pharmaceutical and Medical Device Distribution: Distribution of prescription pharmaceuticals, medical devices, and medical materials to hospitals, clinics, and dispensing pharmacies. Revenue is generated through the margin between wholesale purchase and sale prices to healthcare institutions.
2. Animal Pharmaceutical (A&S) Distribution: Sale of veterinary pharmaceuticals and related products to livestock/fishery operators and animal hospitals.
3. Femcare Consumer Products: Direct-to-consumer sales of the 'And Dears' intimate wash product through the company's e-commerce storefront (Tomita Medical+ online shop) and physical retail locations.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Tomita Pharmaceutical is a regional pharmaceutical wholesaler that distributes prescription pharmaceuticals, medical devices, and medical materials to hospitals, clinics, and dispensing pharmacies across the seven Kyushu prefectures. It also operates an A&S (Animals & Sanitation) division distributing veterinary pharmaceuticals to livestock/fishery operators and animal hospitals, and runs the Tomita Medical+ e-commerce platform selling consumer products including the And Dears femcare brand.

Product overview

Tomita Pharmaceutical operates as a pharmaceutical wholesale distributor based in Kumamoto, Japan, offering two core business divisions: the Medical Pharmaceuticals Division (selling prescription drugs, medical devices, and medical materials to hospitals, clinics, and dispensing pharmacies across the seven Kyushu prefectures) and the A&S (Animals & Sanitation) Division (selling veterinary pharmaceuticals to livestock farmers and animal hospitals). The company also operates a consumer-facing e-commerce platform called 'Tomita Medical+' and developed a proprietary femcare brand 'And Dears' featuring an intimate wash product. Additional services include medical district investigation reports for clinic planning purposes.

Differentiator

Problem solved

Functional benefit

Brands

• And Dears: Feminine intimate care product line featuring 'And Dears Intimate Wash' (インティメイトウォッシュ), a pH-balanced intimate cleansing product launched in 2023. The brand targets women's intimate wellness and is sold through the company's Tomita Medical+ online store.
• Tomita Medical+ (とみたMedical+)

Products and services

• Medical Pharmaceuticals Distribution

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Four partnerships are on record, tiered minor.

• Fukuoka Orange PartnersminorStrategic or Co-development Partner · 29 December 2023Fukuoka Orange Partners is a consortium comprising dementia patients and their families, companies and organizations, and medical, nursing care, and welfare practitioners, along with local government, working together to help people with dementia live independently in their familiar communities. Tomita Pharmaceutical participates to contribute to community health.
• Kumamoto University / Kumamoto Cardiac Rehabilitation Promotion ProjectminorStrategic or Co-development Partner · 29 December 2023Tomita Pharmaceutical donated to the Kumamoto University-led cardiac rehabilitation crowdfunding project, which aims to train more 'cardiac rehabilitation instructors' and promote cardiac rehabilitation programs throughout Kumamoto Prefecture. The donation was designated as a 'specified donation' by the Minister of Finance for its urgency and public interest.
• And Dears Retail PartnersminorChannel Partner/ Reseller/ Distributor · 10 October 2023The And Dears intimate wash product is distributed through partner retail stores across Japan, in addition to the company's own e-commerce platform. A list of participating stores is published on the product website.
• HIROTSU Bio Science (株式会社HIROTSUバイオサイエンス)minorStrategic or Co-development Partner · 8 June 2023Tomita Pharmaceutical entered into a capital and business partnership with HIROTSU Bio Science, a biotech company, to explore new business opportunities in the healthcare sector.

Scale indicators2 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Paltac Corporation: Japan's leading drug wholesaler focused on OTC products, cosmetics, toiletries, and healthcare products distributed to drugstores and pharmacies nationwide. Comparable to Tomita via the wholesale distribution model and Japanese customer base, though Paltac's channel mix skews toward consumer drugstores rather than Tomita's hospital and clinic focus.
• Toho Holdings Co., Ltd. Major Japanese pharmaceutical wholesaler group distributing prescription drugs and medical devices through subsidiaries including Toho Pharmaceutical. Directly comparable to Tomita in distribution model, product mix, and Japanese institutional customer base, with the key difference of national scale and a publicly listed parent providing capital access Tomita lacks.
• Alfresa Holdings Corporation: Top-tier Japanese pharmaceutical wholesaler offering prescription drug distribution, OTC products, and healthcare services across Japan. Directly comparable to Tomita in distribution fundamentals and customer base (hospitals and pharmacies), with the addition of a national footprint and a healthcare-adjacent services portfolio that Tomita is just beginning to build via And Dears and consulting services.
• Suzuken Co., Ltd. Major Japanese pharmaceutical wholesaler covering prescription drugs, medical devices, and diagnostics nationwide with deep hospital and pharmacy relationships. Shares Tomita's distribution-centric model, product portfolio, and customer mix, but operates at national scale with greater centralized procurement leverage.
• Arata Corporation: Major Japanese wholesaler of consumer products including daily necessities, pet supplies, and pharmaceuticals to retailers nationwide. Shares Tomita's wholesale distribution model and Japanese geography, though Arata's product mix is broader and more retail-channel oriented, making it a tangential rather than direct comparator.
• Medipal Holdings Corporation: Japan's largest pharmaceutical wholesaler, distributing prescription drugs, medical devices, and OTC products nationally through subsidiaries including Mediceo. Closely comparable to Tomita via identical B2B pharmaceutical distribution model and Japanese institutional customer base, but operating at materially larger national scale with superior manufacturer negotiating leverage.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tomita Pharmaceutical